Rifaximin is usually used in the treatment of travelers' diarrhea by noninvasive strains of Escherichia coli .
Currently rifaximin is being trialed to evaluate the potential benefits and safety in the treatment of moderate to severe symptoms of Crohn's Disease.
It would be worth checking with the patient to make sure that he/she is aware of the current trial.
- Xifaxan Information for Consumers
- Xifaxan Information for Healthcare Professionals (includes dosage details)
- Side Effects of Xifaxan (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 1 Oct 2012 • 1 answer
Posted 6 Aug 2013 • 1 answer
Posted 16 Jan 2014 • 1 answer
Posted 3 Jan 2015 • 2 answers
Posted 24 May 2017 • 0 answers